ZDRAVESKI ZORAN
CIK: 0001741285•See Remarks
Officer
Primary company: TScan Therapeutics, Inc. (TCRX)
ZDRAVESKI ZORAN is a corporate insider (See Remarks) at TScan Therapeutics, Inc. (TCRX) filing SEC Form 4 transactions. 32 transactions across 2 companies, totaling $35,255 in purchases and $1,339,042 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 250,000 | $3.06 | $766K | 250,000 | 1/3/2025 Filed: 2/11/2025 | Filing → | |
| Award | 52,500 | $6.00 | $315K | 52,500 | 1/12/2024 Filed: 2/11/2025 | Filing → | |
| Exercise | 64,166 | - | - | 365,834 | 8/23/2024 Filed: 8/27/2024 | Filing → | |
| Exercise | 13,125 | - | - | 21,875 | 8/23/2024 Filed: 8/27/2024 | Filing → | |
| Exercise | 25,000 | - | - | 25,000 | 8/23/2024 Filed: 8/27/2024 | Filing → | |
| Exercise | 54,895 | - | - | 30,105 | 8/23/2024 Filed: 8/27/2024 | Filing → | |
| Sale | 164,686 | $5.78 | $952K | 4,716 | 8/23/2024 Filed: 8/27/2024 | Filing → | |
| Exercise | 64,166 | $2.49 | $160K | 169,402 | 8/23/2024 Filed: 8/27/2024 | Filing → | |
| Exercise | 13,125 | $1.81 | $24K | 105,236 | 8/23/2024 Filed: 8/27/2024 | Filing → | |
| Exercise | 25,000 | $3.27 | $82K | 92,111 | 8/23/2024 Filed: 8/27/2024 | Filing → | |
| Exercise | 54,895 | $4.85 | $266K | 67,111 | 8/23/2024 Filed: 8/27/2024 | Filing → | |
| Award | 430,000 | $0.00 | $0 | 430,000 | 6/13/2023 Filed: 6/15/2023 | Filing → | |
| Award | 35,000 | $0.00 | $0 | 35,000 | 2/2/2023 Filed: 2/6/2023 | Filing → | |
| Award | 50,000 | $0.00 | $0 | 50,000 | 7/25/2022 Filed: 7/27/2022 | Filing → | |
| Award | 85,000 | $0.00 | $0 | 85,000 | 1/18/2022 Filed: 1/20/2022 | Filing → | |
| Purchase | 4,716 | $7.48 | $35K | 4,716 | 9/23/2021 Filed: 9/27/2021 | Filing → | |
| Award | 150,000 | $0.00 | $0 | 150,000 | 9/7/2021 Filed: 9/9/2021 | Filing → | |
Magenta Therapeutics, Inc. MGTA | Award | 67,700 | $0.00 | $0 | 67,700 | 2/11/2021 Filed: 2/16/2021 | Filing → |
Magenta Therapeutics, Inc. MGTA | Award | 60,000 | $0.00 | $0 | 60,000 | 2/10/2020 Filed: 2/12/2020 | Filing → |
Magenta Therapeutics, Inc. MGTA | Exercise | 820 | $0.00 | $0 | 16,856 | 12/24/2019 Filed: 12/30/2019 | Filing → |
Type
Award
Shares
250,000
Price
$3.06
Value
$766K
Type
Award
Shares
52,500
Price
$6.00
Value
$315K
Type
Exercise
Shares
64,166
Price
-
Value
-
Type
Exercise
Shares
13,125
Price
-
Value
-
Type
Exercise
Shares
25,000
Price
-
Value
-
Type
Exercise
Shares
54,895
Price
-
Value
-
Type
Sale
Shares
164,686
Price
$5.78
Value
$952K
Type
Exercise
Shares
64,166
Price
$2.49
Value
$160K
Type
Exercise
Shares
13,125
Price
$1.81
Value
$24K
Type
Exercise
Shares
25,000
Price
$3.27
Value
$82K
Type
Exercise
Shares
54,895
Price
$4.85
Value
$266K
Type
Award
Shares
430,000
Price
$0.00
Value
$0
Type
Award
Shares
35,000
Price
$0.00
Value
$0
Type
Award
Shares
50,000
Price
$0.00
Value
$0
Type
Award
Shares
85,000
Price
$0.00
Value
$0
Type
Purchase
Shares
4,716
Price
$7.48
Value
$35K
Type
Award
Shares
150,000
Price
$0.00
Value
$0
Magenta Therapeutics, Inc.
MGTA
Type
Award
Shares
67,700
Price
$0.00
Value
$0
Magenta Therapeutics, Inc.
MGTA
Type
Award
Shares
60,000
Price
$0.00
Value
$0
Magenta Therapeutics, Inc.
MGTA
Type
Exercise
Shares
820
Price
$0.00
Value
$0
AI Agent
Try asking...